| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.4 | 0.06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |